World's Best Scientists 2026 revealed!
Journal of Psychoactive Drugs
H-index 15

Journal of Psychoactive Drugs

0279-1072

Published by: Taylor & Francis

https://www.tandfonline.com/toc/ujpd20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Psychology 534 57 67 13
Medicine 3075 18 23 5

Additional Metrics

Number of Best Scientists*: 100
Documents by Best Scientists*: 122
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 74
SCIMAGO SJR: 0.833
Impact Factor: 2.2

Overview

Top Research Topics at Journal of Psychoactive Drugs?

Journal of Psychoactive Drugs generally zeroes in on subjects such as Psychiatry, Substance abuse, Addiction, Clinical psychology and Public health. Studies on Psychiatry discussed in Journal of Psychoactive Drugs link to the field of Suicide prevention. Topics in Substance abuse explored in it were investigated in conjunction with research in Psychological intervention, Injury prevention, Acquired immunodeficiency syndrome (AIDS) and MEDLINE.

The studies tackled, which mainly focus on Addiction, apply to Psychotherapist as well. The work tackled in Journal of Psychoactive Drugs goes beyond the discipline of Public health as it also encompasses Gerontology. The Methadone research dealing mostly with Methadone maintenance is the focus of the journal.

  • Psychiatry (45.60%)
  • Substance abuse (27.53%)
  • Addiction (19.02%)

What are the most cited papers published in the journal?

  • Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. (747 citations)
  • The Clinical Opiate Withdrawal Scale (COWS) (566 citations)
  • The Historical Trauma Response Among Natives and Its Relationship with Substance Abuse: A Lakota Illustration (488 citations)

Research areas of the most cited articles at Journal of Psychoactive Drugs:

The journal papers generally zeroe in on subjects such as Psychiatry, Substance abuse, Addiction, Clinical psychology and Public health. While Psychiatry is the focus of the journal articles, it also provides insights into the studies of Injury prevention, Suicide prevention and MEDLINE. The most cited publications tackle studies in Acquired immunodeficiency syndrome (AIDS) and the interrelated subject of Risk factor to gain insights into Substance abuse.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Law
  • Psychiatry

The previous edition focused in particular on these issues:

Psychiatry, Cannabis, Clinical psychology, Substance use and Addiction are among the topics commonly tackled in the journal. Research in Opioid and the interrelating topic of Methadone and Heroin were among the subjects of interest in the Psychiatry studies discussed in Journal of Psychoactive Drugs. The studies in Cannabis featured incorporate elements of Harm reduction, Legalization, Spirituality and Young adult.

Topics in Clinical psychology were tackled in line with various other fields like Feeling and Perception. The Substance use works featured in the journal incorporate elements from Developmental psychology, Impulsivity, Qualitative research and Logistic regression. While the primary focus in Journal of Psychoactive Drugs is Addiction, it also dissects topics surrounding Depression (differential diagnoses) and Internal medicine as a whole.

The most cited articles from the last journal are:

  • Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19. (31 citations)
  • Chemical Composition of Traditional and Analog Ayahuasca. (6 citations)
  • The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Psychoactive Drugs (based on the number of publications) are:

  • David Smith (62 papers) absent at the last edition,
  • Richard A. Rawson (35 papers) absent at the last edition,
  • Ronald K. Siegel (23 papers) absent at the last edition,
  • James A. Inciardi (22 papers) absent at the last edition,
  • Richard B. Seymour (20 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Psychoactive Drugs (based on the number of publications) are:

  • University of California, San Francisco (122 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • University of California, Los Angeles (97 papers) absent at the last edition,
  • Harvard University (37 papers) published 1 paper at the last edition the same number as at the previous edition,
  • University of California, San Diego (33 papers) absent at the last edition,
  • National Development and Research Institutes (31 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.41% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.33% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.96% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.81% of all publications and 58.90% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Academic Institutions Contributing to the Journal

The academic institutions that contribute to the Journal of Psychoactive Drugs play a pivotal role in the research produced. These institutions provide the environment and resources for researchers to explore diverse topic areas in depth. They foster innovative thinking and help in the expansion of knowledge within the realm of psychoactive drugs and related topics. A list of institutions that often contribute to the Journal of Psychoactive Drugs comprises universities and colleges globally renowned for their Psychology Departments. A brief analysis showcases that many researchers contributing to the journal are associated with the top Psychology Departments worldwide. This connection enhances the credibility and scholarly value of the research published in the journal. < a href="/universities-colleges/best-psychology-schools-in-maine">Maine's best psychology schools< /a> produce scholars passionate about studying psychoactive drugs. Their advanced programs stimulate high-quality research widely accepted in journals like the Journal of Psychoactive Drugs. The frequent contribution from these establishments underscores the importance of academic institutions in the realm of psychoactive drug research and highlights the need for continuous investment in infrastructure and resources to support them.

Top Publications

  • Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19.

    Viviana E Horigian;Renae D Schmidt;Daniel J Feaster

    (2021)
    344 Citations
  • A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy.

    Jason B Luoma;Christina Chwyl;Geoff J Bathje;Alan K Davis;Alan K Davis

    (2020)
    177 Citations
  • Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.

    Alan K Davis;Alan K Davis;Gabrielle Agin-Liebes;Gabrielle Agin-Liebes;Megan España;Brian Pilecki

    (2021)
    59 Citations
  • Influence of Family Factors on Substance Use in Early Adolescents: A Longitudinal Study in Hong Kong

    Daniel T. L. Shek;Xiaoqin Zhu;Diya Dou;Wenyu Chai

    (2020)
    51 Citations
  • Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin

    Tracey Varker;Loretta Watson;Kari Gibson;David Forbes

    (2021)
    34 Citations
  • Ayahuasca's Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

    Maha N Mian;B R Altman;M Earleywine

    (2020)
    34 Citations
  • Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States

    (2022)
    32 Citations
  • Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users

    (2022)
    28 Citations
  • Trends in the Top-Cited Articles on Classic Psychedelics.

    David Wyndham Lawrence;David Wyndham Lawrence;Bhanu Sharma;Bhanu Sharma;Roland R. Griffiths;Robin Carhart-Harris

    (2021)
    26 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional medical degrees, several online options offer flexible pathways into healthcare. Programs like online healthcare degrees provide accelerated routes for students aiming to enter leadership roles in medical settings. These programs are designed to equip graduates with essential skills in healthcare management and policy.

Affordability is a critical consideration. Exploring options such as the health care administration online degree can help students pursue quality education without excessive debt. These degrees often offer strong career outcomes while being financially accessible.

For direct patient care roles, the most affordable online nurse practitioner programs allow registered nurses to advance their clinical skills and gain autonomy in various healthcare environments. Similarly, the affordable online nursing programs serve as excellent entry points for individuals starting their nursing careers or seeking RN licensure.

These diverse online paths not only support career growth but also provide greater accessibility for students balancing work, study, and life commitments.

Best Scientists Contributing to This Journal